The CBD-Intel Food hub provides access to news and reports on regulatory and market developments related to food, drink and dietary supplements.
Our in-house team of experts share research and insight into issues impacting CBD food products around the globe, including news from the EU, which has classified CBD products as a novel food.
Tim Phillips, CBD-Intel’s managing director, recently presented at CBD Live during VOXPO – Virtual Online Vape & CBD Expo on 28th April 2021. In addition to an overview of the impact of Covid-19 on the retail environment, he provided a comparative analysis of the current Novel Food legislation in the UK and the US, as […]
It does not look like good news. The only two companies (controlling three brands that contain 23 individually listed products) included in the initial list of validated applications both say they submitted their applications to the FSA in early January. Both also are at least partly based on synthetic CBD ingredients that have successfully navigated […]
Berta Camps Bisbal, CBD-Intel’s senior legal analyst, presented a comparative analysis of state laws in the US at CBD Live during VOXPO – Virtual Online Vape & CBD Expo on 18th November. She presented an overview of the federal farm bill as well as CBD at the federal level versus state level. You can now […]
Concerns over traceability, limiting final use and demonstrating safety of final products could make it difficult to grant UK novel food approval to CBD ingredients producers and white label manufacturers
CBD-Intel managing director, Tim Phillips, discusses the main facts and issues surrounding CBD and Novel Food status in European markets. He presents the key aspects of the delay, the political issues and the impacts released on the European level and the future challenges for the sector.
Enforcement activity against food, drink and dietary supplement products placed on the market containing CBD continues despite the inability of companies to proceed with novel food applications due to the EC’s questions over whether CBD constitutes a narcotic under the 1961 UN Single Convention on Narcotics.
Several major developments have all happened at the same time for novel foods. Perhaps most importantly, one of the European Commission’s departments – the Directorate-General for Health and Food Safety – has said it is holding sending any further non-synthetic CBD applications to the European Food Safety Authority for evaluation until it has determined whether CBD technically falls under the definition of a narcotic according to the 1961 UN Single Convention on Narcotic Drugs.
Progress on novel food authorisations for non-synthetic cannabinoids will be paused until European regulators decide whether extracts from hemp flowers constitute a drug under narcotics laws, CBD-Intel has learned
A new line of sparkling CBD drinks is to be launched in the Colorado market in what may be an indication of how high-profile companies approach the CBD market during its continued period of uncertainty
Scotland has not followed the rest of the UK in setting a deadline for novel food applications, while the Republic of Ireland has adopted an even more conservative approach, stating that unauthorised novel foods should not be on the market at all
Companies selling foods containing CBD appear to be ignoring the UK Food Standards Agency (FSA)’s latest warning about the EU’s novel foods legislation – because, some of them claim, it has no legal weight
The CBD industry navigates a complex and changing regulatory landscape across the world, with parts of the industry operating in a grey area. This is particularly the case for one of the most popular product categories on the market: edibles
The Centre for Medical Cannabis is launching a new Association for the Cannabinoid Industry (ACI), claiming to be the first CBD trade organisation in the UK to ensure compliance with EU novel food regulations
The EU defines a novel food as a food that had not been consumed to a significant degree by humans in the EU before 15 May 1997, when the first regulation on novel food came into force.
This means CBD products launched within the EU must confirm with the underlying principles: it must be safe and appropriately labelled so that it doesn’t mislead consumers.
Novel foods need to obtain pre-market authorisation before being launched on the market in the EU.
To further complicate matters, the UK has now left the EU, which CBD foods to be launched in the UK need to obtain authorisation from the UK’s Food Standards Authority (FSA).
Stay on top of the complex and ever-changing regulatory landscape with our regular updates.
CBD-Intel provides impartial, independent and premium market and regulatory analysis, legal tracking, and quantitative data for the cannabidiol (CBD) sector worldwide. Most content is available to subscribers only.